- Home
- GDTC vs AZI Comparison
GDTC vs AZI Comparison
Compare GDTC & AZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- AZI
- Stock Information
- Founded
- GDTC 2018
- AZI 2010
- Country
- GDTC Singapore
- AZI China
- Employees
- GDTC N/A
- AZI N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- AZI
- Sector
- GDTC Health Care
- AZI
- Exchange
- GDTC Nasdaq
- AZI Nasdaq
- Market Cap
- GDTC 22.9M
- AZI 25.2M
- IPO Year
- GDTC 2023
- AZI 2024
- Fundamental
- Price
- GDTC $1.90
- AZI $0.22
- Analyst Decision
- GDTC Buy
- AZI
- Analyst Count
- GDTC 1
- AZI 0
- Target Price
- GDTC $5.00
- AZI N/A
- AVG Volume (30 Days)
- GDTC 9.9K
- AZI 1.6M
- Earning Date
- GDTC 01-01-0001
- AZI 01-01-0001
- Dividend Yield
- GDTC N/A
- AZI N/A
- EPS Growth
- GDTC N/A
- AZI N/A
- EPS
- GDTC N/A
- AZI N/A
- Revenue
- GDTC $368,838.00
- AZI $124,737,000.00
- Revenue This Year
- GDTC $5.37
- AZI N/A
- Revenue Next Year
- GDTC N/A
- AZI N/A
- P/E Ratio
- GDTC N/A
- AZI N/A
- Revenue Growth
- GDTC N/A
- AZI 9.86
- 52 Week Low
- GDTC $1.20
- AZI $0.19
- 52 Week High
- GDTC $4.05
- AZI $3.30
- Technical
- Relative Strength Index (RSI)
- GDTC 48.17
- AZI 41.82
- Support Level
- GDTC $1.85
- AZI $0.22
- Resistance Level
- GDTC $2.07
- AZI $0.24
- Average True Range (ATR)
- GDTC 0.08
- AZI 0.01
- MACD
- GDTC 0.02
- AZI 0.00
- Stochastic Oscillator
- GDTC 51.12
- AZI 2.86
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.